Observational studyPloS one2025

Assessment of the impact of the new blister packaging of Biktarvy® (B/F/TAF) on treatment satisfaction of people living with HIV.

João Paulo Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.